Find Your Community.
Join conversations and connect with others who truly understand
your journey
Focused conversations. Real insight. Right people.
No noise. Real connection, science-backed insights, and real-world support.
Clubs by Disease Type
Join the conversations that matter after diagnosis – from accessing the right treatment and expert advice to discovering trials most patients never hear about.
Find your people – a space where every conversation is with someone who truly understands your journey. Beyond belonging, unlock access to the latest options in cancer care, personalized insights for your cancer type, and trusted guidance from genetic counsellors and top oncologists.
Breast Cancer Club
“In the darkest times, we don’t just seek light—we become it, illuminating our own and each other’s path with strength and grace.”
Whether it is HR+, HER2+, HRD, BRCA-mutated, or facing TNBC- A space for women navigating targeted therapies, exploring genetic counseling, seeking second opinions from top oncologists, discussing hard-to-find clinical trials, learning and sharing personal journeys while making sense of their unique disease and mutations
Join Breast Cancer Club ->
Lung Cancer Club
“The breath may falter, the will to fight does not—each inhale a quiet act of courage, each exhale a step toward hope.“
From EGFR to ALK and KRAS — A space for understanding mutations, navigating trials, exploring genetic counselling, seeking second opinions from top oncologists, oncologist-backed threads on resistance mutations, NGS reports, and patients sharing personal journeys while making sense of their unique disease and mutations.
Join Lung Cancer Club ->
Ovarian & Women’s Cancer Club
“For women facing questions no one prepares them for.”
From HRD and BRCA to fertility, recurrence, and maintenance — we cover what matters, with input from clinicians and counselors. Join others balancing family planning, surgical decisions, and how to access the most suitable treatment—not just available treatment.
Join Women’s Cancer Club ->
GI Cancer Club (Colon, Stomach, Pancreatic, Biliary)
“These cancers don’t follow templates — and neither do our conversations.”
Talk to patients and experts navigating MSI status, BRAF, KRAS, and immunotherapy for GI cancers. Learn where to test, what to ask, and how to join emerging clinical trials or access drugs not always available locally.
Join GI Cancer Club ->
Rare & Less Common Cancer Club
“If your diagnosis doesn’t fit the menu, you’re in the right place.”
From NETs to sarcomas and fusions, this space bridges isolation with information. Ask about trial navigation, latest approvals, and how to make sense of NGS results when doctors don’t explain them.
Join Rare Cancers Club ->
Clubs by Diagnosis / Disease Type
Join the conversations that matter after diagnosis – from accessing the right treatment and expert advice to discovering trials most patients never hear about.
Find your people – a space where every conversation is with someone who truly understands your journey. Beyond belonging, unlock access to the latest options in cancer care, personalized insights for your cancer type, and trusted guidance from genetic counsellors and top oncologists.
Breast Cancer Club
“In the darkest times, we don’t just seek light—we become it, illuminating our own and each other’s path with strength and grace.”
Whether it is HR+, HER2+, HRD, BRCA-mutated, or facing TNBC- A space for women navigating targeted therapies, exploring genetic counseling, seeking second opinions from top oncologists, discussing hard-to-find clinical trials, learning and sharing personal journeys while making sense of their unique disease and mutations
Join Breast Cancer Club ->
Lung Cancer Club
“The breath may falter, the will to fight does not—each inhale a quiet act of courage, each exhale a step toward hope.“
From EGFR to ALK and KRAS — A space for understanding mutations, navigating trials, exploring genetic counselling, seeking second opinions from top oncologists, oncologist-backed threads on resistance mutations, NGS reports, and patients sharing personal journeys while making sense of their unique disease and mutations.
Join Lung Cancer Club ->
Ovarian & Women’s Cancer Club
“For women facing questions no one prepares them for.”
From HRD and BRCA to fertility, recurrence, and maintenance — we cover what matters, with input from clinicians and counselors. Join others balancing family planning, surgical decisions, and how to access the most suitable treatment—not just available treatment.
Join Women’s Cancer Club ->
GI Cancer Club (Colon, Stomach, Pancreatic, Biliary)
“These cancers don’t follow templates — and neither do our conversations.”
Talk to patients and experts navigating MSI status, BRAF, KRAS, and immunotherapy for GI cancers. Learn where to test, what to ask, and how to join emerging clinical trials or access drugs not always available locally.
Join GI Cancer Club ->
Rare & Less Common Cancer Club
“If your diagnosis doesn’t fit the menu, you’re in the right place.”
From NETs to sarcomas and fusions, this space bridges isolation with information. Ask about trial navigation, latest approvals, and how to make sense of NGS results when doctors don’t explain them.
Join Rare Cancers Club ->
Clubs by Diagnosis / Disease Type
Join the conversations that matter after diagnosis – from accessing the right treatment and expert advice to discovering trials most patients never hear about.
Find your people – a space where every conversation is with someone who truly understands your journey. Beyond belonging, unlock access to the latest options in cancer care, personalized insights for your cancer type, and trusted guidance from genetic counsellors and top oncologists.
Breast Cancer Club
“In the darkest times, we don’t just seek light—we become it, illuminating our own and each other’s path with strength and grace.”
Whether it is HR+, HER2+, HRD, BRCA-mutated, or facing TNBC- A space for women navigating targeted therapies, exploring genetic counseling, seeking second opinions from top oncologists, discussing hard-to-find clinical trials, learning and sharing personal journeys while making sense of their unique disease and mutations
Join Breast Cancer Club ->
Lung Cancer Club
“The breath may falter, the will to fight does not—each inhale a quiet act of courage, each exhale a step toward hope.“
From EGFR to ALK and KRAS — A space for understanding mutations, navigating trials, exploring genetic counselling, seeking second opinions from top oncologists, oncologist-backed threads on resistance mutations, NGS reports, and patients sharing personal journeys while making sense of their unique disease and mutations.
Join Lung Cancer Club ->
Ovarian & Women’s Cancer Club
“For women facing questions no one prepares them for.”
From HRD and BRCA to fertility, recurrence, and maintenance — we cover what matters, with input from clinicians and counselors. Join others balancing family planning, surgical decisions, and how to access the most suitable treatment—not just available treatment.
Join Women’s Cancer Club ->
GI Cancer Club (Colon, Stomach, Pancreatic, Biliary)
“These cancers don’t follow templates — and neither do our conversations.”
Talk to patients and experts navigating MSI status, BRAF, KRAS, and immunotherapy for GI cancers. Learn where to test, what to ask, and how to join emerging clinical trials or access drugs not always available locally.
Join GI Cancer Club ->
Rare & Less Common Cancer Club
“If your diagnosis doesn’t fit the menu, you’re in the right place.”
From NETs to sarcomas and fusions, this space bridges isolation with information. Ask about trial navigation, latest approvals, and how to make sense of NGS results when doctors don’t explain them.
Join Rare Cancers Club ->
Clubs by Mutations & Biomarker
Cancer isn’t one disease. It’s a molecular profile. These clubs go beyond diagnosis — connecting you to biomarker-specific care, trials, and access.
Mishra, Alok & Ali, Amjad & Dutta, Shubham & Banday, Shahid & Malonia, Sunil. (2022). Emerging Trends in Immunotherapy for Cancer. Diseases. 10. 60. 10.3390/diseases10030060.
Immunotherapy Responders Club
Mutations Covered: MSI-high, dMMR, PD-L1+, TMB-high
Key Cancer Types: Lung, Head & Neck, Bladder, Endometrial, Colorectal, Gastric
“Checkpoint inhibitors change everything — or nothing. Know the difference.”
Learn what predicts success, how to handle immune-related side effects, and where trials or second-line options are still available.
Oncologist-backed guidance + patient stories + India-specific access tips.
Miri, Ali & Kiani, Ebrahim & Habibi, Sajad & Khafaei, Mostafa & Cas Press, Cajmpsi. (2021). Triple-negative breast cancer: biology, pathology, and treatment. 1. 81-96. 10.22034/CAJMPSI.2021.02.05.
HER2+ & EGFR Club
Mutations Covered: HER2 amplification/mutation, EGFR ex19, L858R, T790M
Key Cancer Types: Breast, Gastric, Lung, Biliary, Colorectal, Head & Neck
“HER2 and EGFR aren’t just labels — they shape your treatment roadmap.”
For those on ADCs, TKIs, or dealing with resistance — connect across cancers and discuss how to access next-line treatments and trials.
Practical support with sequencing, testing, and drug access challenges.
Song Y, Bi Z, Liu Y, Qin F, Wei Y, Wei X. Targeting RAS-RAF-MEK-ERK signaling pathway in human cancer: Current status in clinical trials. Genes Dis. 2022 May 20;10(1):76-88. doi: 10.1016/j.gendis.2022.05.006. PMID: 37013062; PMCID: PMC10066287.
RAS Pathway Club
Mutations Covered: KRAS (G12C/G12D), NRAS, BRAF
Key Cancer Types: NSCLC, Colorectal, Pancreatic, Melanoma
“Used to be undruggable. Not anymore.”
G12C inhibitors, BRAF V600E, emerging combos — plus what it takes to get access and affordability in real life.
Cross-cancer, cross-country insights on trials, resistance, and side effects.
Witz, A., Dardare, J., Betz, M. et al. Homologous recombination deficiency (HRD) testing landscape: clinical applications and technical validation for routine diagnostics. Biomark Res 13, 31 (2025). https://doi.org/10.1186/s40364-025-00740-y
BRCA & HRD Club
Mutations Covered: BRCA1/2, PALB2, ATM, CHEK2
Key Cancer Types: Breast, Ovarian, Pancreatic, Prostate
“When you inherit risk, decisions get more complex — and more urgent.”
From preventive surgery to family counseling and PARP access, this is where hereditary cancer choices get discussed clearly.
Engage with genetic counselors and others facing similar decisions.
Liu, L.; Graff, S.L.; Wang, Y. New Emerging Therapies Targeting PI3K/AKT/mTOR/PTEN Pathway in Hormonal Receptor-Positive and HER2-Negative Breast Cancer—Current State and Molecular Pathology Perspective. Cancers 2025, 17, 16. https://doi.org/10.3390/cancers17010016
PI3K-AKT & Hormone Pathway Club
Mutations Covered: PIK3CA, PTEN, AKT1
Key Cancer Types: HR+ Breast, Endometrial, Prostate, Gallbladder
“When HR+ cancers aren’t simple anymore.”
Navigate alpelisib, everolimus, CDK inhibitors, and hormone therapy complexity with expert insights and patient experiences.
India-specific discussions on access, cost, and what actually works.
Liu, S.V., Nagasaka, M., Atz, J. et al. Oncogenic gene fusions in cancer: from biology to therapy. Sig Transduct Target Ther 10, 111 (2025). https://doi.org/10.1038/s41392-025-02161-7
Fusion-Driven Rare Cancers Club
Mutations Covered: ALK, RET, NTRK, ROS1, METex14, FGFR2/3
Key Cancer Types: Thyroid, NSCLC, Cholangiocarcinoma, Pediatric Cancers
“Low-incidence fusions. High-stakes decisions.”
For anyone managing rare actionable fusions — talk NGS reports, approvals, drug resistance, and global access stories.
Practical help for interpreting reports, finding fusion-specific trials, and accessing next-gen therapies.
Mishra, Alok & Ali, Amjad & Dutta, Shubham & Banday, Shahid & Malonia, Sunil. (2022). Emerging Trends in Immunotherapy for Cancer. Diseases. 10. 60. 10.3390/diseases10030060.
Immunotherapy Responders Club
Mutations Covered: MSI-high, dMMR, PD-L1+, TMB-high
Key Cancer Types: Lung, Head & Neck, Bladder, Endometrial, Colorectal, Gastric
“Checkpoint inhibitors change everything — or nothing. Know the difference.”
Learn what predicts success, how to handle immune-related side effects, and where trials or second-line options are still available.
Oncologist-backed guidance + patient stories + India-specific access tips.
Miri, Ali & Kiani, Ebrahim & Habibi, Sajad & Khafaei, Mostafa & Cas Press, Cajmpsi. (2021). Triple-negative breast cancer: biology, pathology, and treatment. 1. 81-96. 10.22034/CAJMPSI.2021.02.05.
HER2+ & EGFR Club
Mutations Covered: HER2 amplification/mutation, EGFR ex19, L858R, T790M
Key Cancer Types: Breast, Gastric, Lung, Biliary, Colorectal, Head & Neck
“HER2 and EGFR aren’t just labels — they shape your treatment roadmap.”
For those on ADCs, TKIs, or dealing with resistance — connect across cancers and discuss how to access next-line treatments and trials.
Practical support with sequencing, testing, and drug access challenges.
Song Y, Bi Z, Liu Y, Qin F, Wei Y, Wei X. Targeting RAS-RAF-MEK-ERK signaling pathway in human cancer: Current status in clinical trials. Genes Dis. 2022 May 20;10(1):76-88. doi: 10.1016/j.gendis.2022.05.006. PMID: 37013062; PMCID: PMC10066287.
RAS Pathway Club
Mutations Covered: KRAS (G12C/G12D), NRAS, BRAF
Key Cancer Types: NSCLC, Colorectal, Pancreatic, Melanoma
“Used to be undruggable. Not anymore.”
G12C inhibitors, BRAF V600E, emerging combos — plus what it takes to get access and affordability in real life.
Cross-cancer, cross-country insights on trials, resistance, and side effects.
Witz, A., Dardare, J., Betz, M. et al. Homologous recombination deficiency (HRD) testing landscape: clinical applications and technical validation for routine diagnostics. Biomark Res 13, 31 (2025). https://doi.org/10.1186/s40364-025-00740-y
BRCA & HRD Club
Mutations Covered: BRCA1/2, PALB2, ATM, CHEK2
Key Cancer Types: Breast, Ovarian, Pancreatic, Prostate
“When you inherit risk, decisions get more complex — and more urgent.”
From preventive surgery to family counseling and PARP access, this is where hereditary cancer choices get discussed clearly.
Engage with genetic counselors and others facing similar decisions.
Liu, L.; Graff, S.L.; Wang, Y. New Emerging Therapies Targeting PI3K/AKT/mTOR/PTEN Pathway in Hormonal Receptor-Positive and HER2-Negative Breast Cancer—Current State and Molecular Pathology Perspective. Cancers 2025, 17, 16. https://doi.org/10.3390/cancers17010016
PI3K-AKT & Hormone Pathway Club
Mutations Covered: PIK3CA, PTEN, AKT1
Key Cancer Types: HR+ Breast, Endometrial, Prostate, Gallbladder
“When HR+ cancers aren’t simple anymore.”
Navigate alpelisib, everolimus, CDK inhibitors, and hormone therapy complexity with expert insights and patient experiences.
India-specific discussions on access, cost, and what actually works.
Liu, S.V., Nagasaka, M., Atz, J. et al. Oncogenic gene fusions in cancer: from biology to therapy. Sig Transduct Target Ther 10, 111 (2025). https://doi.org/10.1038/s41392-025-02161-7
Fusion-Driven Rare Cancers Club
Mutations Covered: ALK, RET, NTRK, ROS1, METex14, FGFR2/3
Key Cancer Types: Thyroid, NSCLC, Cholangiocarcinoma, Pediatric Cancers
“Low-incidence fusions. High-stakes decisions.”
For anyone managing rare actionable fusions — talk NGS reports, approvals, drug resistance, and global access stories.
Practical help for interpreting reports, finding fusion-specific trials, and accessing next-gen therapies.